Please login to the form below

Not currently logged in


This page shows the latest Synairgen news and features for those working in and with pharma, biotech and healthcare.

UK biotech Synairgen reveals promising early results for COVID-19 drug

UK biotech Synairgen reveals promising early results for COVID-19 drug

Results from a phase 1 trial of Synairgen’s lead COVID-19 candidate SNG001 demonstrated a significant reduction in the risk of developing severe disease compared to placebo. ... Synairgen found that treatment with its drug resulted in a 79% lower risk

Latest news

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....